2D materials-based devices and systems for biomedical applications (RIA)

Call Updates

Mar 13, 2023 2:36:28 PM
Call for proposals: HORIZON-CL4-2022-DIGITAL-EMERGING-02

Deadline: 16 November 2022

Available budget: EUR 127.000.000

The Commission has now completed the evaluation of the proposals submitted to the above-mentioned call.

The results of the evaluation are as follows:

Number of proposals submitted (including proposals transferred from or to other calls): 266

Number of inadmissible proposals: 0

Number of ineligible proposals: 4

Number of above-threshold proposals: 141

Total budget requested for above-threshold proposals: EUR 793.751.643

We recently informed the applicants about the evaluation results for their proposals.

It is expected that the first grant agreements will be signed by June 2023.

Information on the selected projects will be published on CORDIS[1] after that date.

Please note that the number of proposals that can finally be funded will depend on the finally available budget and the formal selection by the Commission.

For questions, please contact the Research Enquiry Service[2].

Nov 22, 2022 5:32:03 PM

CORRIGENDUM (incorrect formatting)

Submissions to the call HORIZON-CL4-2022-DIGITAL-EMERGING-02:

A total of 266 proposals has been submitted to the call HORIZON-CL4-2022-DIGITAL-EMERGING-02, which closed on 16 November 2022. These proposals, of which the evaluation will be organized over the coming weeks and months, were submitted to the following topics:

HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 - 2D materials-based devices and systems for biomedical applications (RIA) – 21 proposals

Nov 22, 2022 2:04:37 PM

Submissions to call HORIZON-CL4-2022-DIGITAL-EMERGING-02

A total of 266 proposals has been submitted to call HORIZON-CL4-2022-DIGITAL-EMERGING-02, which closed on 16 November 2022. These proposals, of which the evaluation will be organized over the coming weeks and months, were submitted to the following topics:

2D materials-based devices and systems for bio [...] HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 21

17 June 2022

The submission session is now available for: HORIZON-CL4-2022-DIGITAL-EMERGING-02-19(HORIZON-RIA)

2D materials-based devices and systems for biomedical applications (RIA)

TOPIC ID: HORIZON-CL4-2022-DIGITAL-EMERGING-02-19

Programme: Horizon Europe Framework Programme (HORIZON)
Call: Digital and emerging technologies for competitiveness and fit for the green deal (HORIZON-CL4-2022-DIGITAL-EMERGING-02)
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions
Type of MGA: HORIZON Action Grant Budget-Based [HORIZON-AG]
Deadline model: single-stage
Planned opening date: 16 June 2022
Deadline date: 16 November 2022 17:00:00 Brussels time

Topic description

ExpectedOutcome:

Proposal results are expected to contribute to the following expected outcomes:

• New technology solutions exploiting the unique properties of 2D materials (2DM) that would reduce cost and increase the efficacy of diagnostics or therapies, or provide new diagnostics or therapies for which there is currently no solution. It would strengthen Europe’s industrial position in, early diagnostics, disease prediction and prevention, disease monitoring and reducing hospitalization time.

Scope:

Proposals should build on the multi-functionality allowed by 2DMs and demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-)sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) to allow continuous health monitoring and built-in pharmacological interventions.

Emphasis of the proposals should have a translational perspective, addressing how the devices and systems will reach the clinic, preferably led by European industry. Furthermore, the proposals should bring together multidisciplinary teams including engineers, material scientists, pharmacologists, biologists, clinicians, patients, and ethics experts. Potential application areas include: engineering & bioengineering of biochemical or bioelectronic diagnostics or therapeutic devices and platforms; sensors for digital health; electronics for brain-computer interfaces, taking advantage of flexible devices; medical imaging in combination with implantable devices (e.g. MRI); graphene for drug delivery of therapeutics (e.g. for neurological disorders). The safety aspects of the proposed technologies should be given proper consideration.

Proposals should include activities aiming at facilitating future exploitation of results.

Proposals should aim at demonstrating by the end of the project fully functional prototypes operating in relevant environment conditions (TRL 5).

The proposal should also cover the contribution to the governance and overall coordination of the Graphene Flagship initiative.